This is a "connection" page, showing publications co-authored by William Creasman and Matthew Kohler.
Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol. 2004 Feb; 92(2):525-9.
Why do we continue to overtreat stage Ia?carcinoma of the cervix? Am J Obstet Gynecol. 2017 10; 217(4):413-417.
Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases? Gynecol Oncol. 2016 08; 142(2):278-82.
How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery? Am J Obstet Gynecol. 2009 Sep; 201(3):260.e1-3.
Controversies surrounding lymphadenectomy and postoperative radiotherapy in the treatment of carcinoma of the endometrium. Future Oncol. 2008 Jun; 4(3):379-87.
Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. Gynecol Oncol. 2005 Sep; 98(3):467-83.
Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol. 2004 Dec; 95(3):593-6.
Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol. 2003 Dec; 91(3):486-93.
A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report. J Low Genit Tract Dis. 2012 Apr; 16(2):145-8.
The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8.
Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2008 Aug; 199(2):196.e1-7.